Lana Medical Company Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	117	160	115	-	-
Market Cap Growth	-27.51%	38.75%	-	-	-
Enterprise Value	126	161	120	-	-
Last Close Price	2.17	2.96	2.13	-	-
PE Ratio	10.39	12.83	-	-	-
PS Ratio	1.19	1.90	2.37	-	-
PB Ratio	-	2.62	2.36	-	-
P/TBV Ratio	-	2.63	2.37	-	-
P/OCF Ratio	-	406.51	112.52	-	-
EV/Sales Ratio	1.29	1.92	2.47	-	-
EV/EBITDA Ratio	8.30	14.43	107.83	-	-
EV/EBIT Ratio	10.34	19.03	-	-	-
Debt / Equity Ratio	-	0.25	0.23	0.16	0.21
Debt / EBITDA Ratio	-	1.29	7.11	0.94	1.04
Debt / FCF Ratio	-	-	-	15.15	-
Net Debt / Equity Ratio	-	0.15	-0.15	0.09	0.13
Net Debt / EBITDA Ratio	-	0.81	-6.67	0.56	0.65
Net Debt / FCF Ratio	-	-2.43	3.06	8.50	-0.43
Asset Turnover	-	0.94	0.70	0.68	-
Inventory Turnover	-	15.44	8.34	5.37	-
Quick Ratio	-	1.47	2.38	3.34	4.52
Current Ratio	-	1.87	3.03	4.16	5.39
Return on Equity (ROE)	-	22.70%	-4.00%	12.34%	-
Return on Assets (ROA)	-	5.92%	-0.33%	6.77%	-
Return on Invested Capital (ROIC)	17.98%	13.93%	-0.79%	11.00%	13.24%
Return on Capital Employed (ROCE)	-	11.80%	-0.60%	12.40%	14.80%
Earnings Yield	9.57%	7.80%	-1.67%	-	-
FCF Yield	-10.05%	-2.33%	-2.11%	-	-
Buyback Yield / Dilution	-7.21%	-18.38%	-1.37%	-37.11%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.